Article

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes Defined by International Consensus Classification

2023-03-24

Abstract excerpt

<title>Abstract</title> <p>Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines clinical parameters, cytogenetic abnormalities, and mutation topography was proposed. This study validated the IPSS-M in 649 patients with primary...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 963746c8-2230-513c-88b6-4561fae0adec
DOI: 10.21203/rs.3.rs-2702564/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes Defined by International Consensus ClassificationDOI 10.21203/rs.3.rs-2702564/v1Read

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.Semantic proximity Read

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.Semantic proximity Read

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read

When to use which molecular prognostic scoring system in the management of patients with MDS?Semantic proximity Read

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.Semantic proximity Read

Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity Read

[Molecular international prognostic scoring system for myelodysplastic syndromes].Semantic proximity Read

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read

Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/NeoplasmsSemantic proximity Read

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.Semantic proximity Read

Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53-mutated Myelodysplastic Neoplasms.Semantic proximity Read

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read